P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
2,900.00
-15.00 (-0.51%)
At close: Jun 5, 2025, 3:30 PM KST
P&K Skin Research Center Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 2,169 | 6,461 | 9,797 | 4,982 |
Short-Term Investments | - | 3,761 | 13,037 | - |
Trading Asset Securities | 36,508 | 30,489 | 21,854 | 52,481 |
Cash & Short-Term Investments | 38,677 | 40,711 | 44,688 | 57,463 |
Cash Growth | -18.88% | -8.90% | -22.23% | - |
Accounts Receivable | 1,941 | 1,372 | 1,670 | 1,898 |
Other Receivables | 654.01 | 642.79 | 1,188 | 686.01 |
Receivables | 5,995 | 5,414 | 5,908 | 2,584 |
Prepaid Expenses | 896.49 | 903.54 | 468.39 | 289.65 |
Other Current Assets | 769.93 | 1,135 | 14.72 | 22.31 |
Total Current Assets | 46,339 | 48,164 | 51,079 | 60,359 |
Property, Plant & Equipment | 4,192 | 3,639 | 4,639 | 4,571 |
Long-Term Investments | 32,004 | 29,216 | 19,761 | 8,499 |
Other Intangible Assets | 198.35 | 198.35 | 198.35 | 165.01 |
Long-Term Deferred Tax Assets | 291.14 | 328.11 | 4.78 | 67.88 |
Other Long-Term Assets | 857.76 | 494.02 | 1,725 | 877.46 |
Total Assets | 83,882 | 82,040 | 77,407 | 74,539 |
Accrued Expenses | 1,389 | 1,608 | 981.33 | 1,125 |
Current Portion of Leases | 355.7 | 358.39 | 354.27 | 331.81 |
Current Income Taxes Payable | 475.58 | 738.34 | - | 526.57 |
Other Current Liabilities | 2,727 | 2,042 | 1,254 | 1,102 |
Total Current Liabilities | 4,947 | 4,747 | 2,590 | 3,085 |
Long-Term Leases | 407.12 | 164.64 | 313.96 | 409.2 |
Other Long-Term Liabilities | 322.04 | 272.17 | 263.81 | 238.2 |
Total Liabilities | 5,676 | 5,184 | 3,168 | 3,732 |
Common Stock | 15,005 | 15,005 | 15,005 | 15,005 |
Additional Paid-In Capital | 13,323 | 13,323 | 13,323 | 13,323 |
Retained Earnings | 52,784 | 51,406 | 46,304 | 42,363 |
Treasury Stock | -2,996 | -2,996 | -610.61 | - |
Comprehensive Income & Other | 197.67 | 197.67 | 181.83 | 116.12 |
Total Common Equity | 78,314 | 76,935 | 74,203 | 70,807 |
Minority Interest | -107.35 | -79.33 | 36.25 | - |
Shareholders' Equity | 78,206 | 76,856 | 74,239 | 70,807 |
Total Liabilities & Equity | 83,882 | 82,040 | 77,407 | 74,539 |
Total Debt | 762.82 | 523.03 | 668.23 | 741.01 |
Net Cash (Debt) | 37,914 | 40,188 | 44,019 | 56,722 |
Net Cash Growth | -19.52% | -8.70% | -22.39% | - |
Net Cash Per Share | 1311.01 | 1384.13 | 1467.71 | 1902.25 |
Filing Date Shares Outstanding | 28.73 | 28.88 | 29.77 | 30.01 |
Total Common Shares Outstanding | 28.73 | 28.88 | 29.77 | 30.01 |
Working Capital | 41,392 | 43,417 | 48,489 | 57,274 |
Book Value Per Share | 2726.29 | 2663.79 | 2492.92 | 2359.40 |
Tangible Book Value | 78,115 | 76,737 | 74,005 | 70,642 |
Tangible Book Value Per Share | 2719.38 | 2656.93 | 2486.25 | 2353.91 |
Machinery | 2,732 | 8,521 | 7,999 | 6,672 |
Construction In Progress | - | 86.48 | 70.77 | 184.77 |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.